Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 23592516)

  • 1. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
    Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
    Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotection against beta-amyloid (Aβ) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells.
    Youn P; Chen Y; Furgeson DY
    Neurosci Res; 2015 May; 94():70-8. PubMed ID: 25612817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin.
    Tanigawa S; Fujii M; Hou DX
    Free Radic Biol Med; 2007 Jun; 42(11):1690-703. PubMed ID: 17462537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hepatic oxidative stress enhance activation of nuclear factor-E2-related factor in patients with nonalcoholic steatohepatitis?
    Takahashi Y; Kobayashi Y; Kawata K; Kawamura K; Sumiyoshi S; Noritake H; Watanabe S; Chida T; Souda K; Sakaguchi T; Nakamura H; Suda T
    Antioxid Redox Signal; 2014 Jan; 20(3):538-43. PubMed ID: 23822105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
    Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
    Yang SP; Yang XZ; Cao GP
    Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro.
    Xue Y; Wei Y; Cao L; Shi M; Sheng J; Xiao Q; Cheng Z; Luo T; Jiao Q; Wu A; Chen C; Zhong L; Zhang C
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116933. PubMed ID: 37482263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
    Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
    Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
    Yang JJ; Tao H; Huang C; Li J
    Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
    Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress.
    Zhang MH; Li J; Zhu XY; Zhang YQ; Ye ST; Leng YR; Yang T; Zhang H; Kong LY
    Free Radic Biol Med; 2021 Feb; 164():1-12. PubMed ID: 33388433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y; Tanigawa S; Kumamoto T; Qin S; Daikoku Y; Miyamori K; Nagai M; Hou DX
    Mol Nutr Food Res; 2013 May; 57(5):854-64. PubMed ID: 23390006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways.
    Shih PH; Hwang SL; Yeh CT; Yen GC
    J Agric Food Chem; 2012 Mar; 60(11):2924-33. PubMed ID: 22364184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
    Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.